SONOMA PHARMACEUTICALS, INC. (SNOA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
36/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseSNOA / S&P -42.25% / 15.20% |
WinSNOA / S&P 47.00% / 15.00% |
LoseSNOA / S&P -48.52% / 50.40% |
| 2026-Q11/3 |
LoseSNOA / S&P -41.48% / -4.33% |
WinSNOA / S&P 36.68% / 11.30% |
LoseSNOA / S&P -35.93% / 27.70% |
| 2025-Q41/3 |
LoseSNOA / S&P -6.19% / 2.65% |
WinSNOA / S&P 26.83% / 9.00% |
LoseSNOA / S&P -20.41% / 13.40% |
| 2025-Q32/3 |
WinSNOA / S&P 36.14% / 8.12% |
WinSNOA / S&P 25.02% / 4.61% |
LoseSNOA / S&P -38.42% / 13.45% |
| 2025-Q22/3 |
WinSNOA / S&P 30.14% / 10.94% |
WinSNOA / S&P 17.43% / 4.83% |
LoseSNOA / S&P -72.35% / 10.63% |
| 2025-Q11/3 |
LoseSNOA / S&P -18.59% / -4.27% |
WinSNOA / S&P 12.19% / 4.98% |
LoseSNOA / S&P -60.77% / 10.57% |
| 2024-Q41/3 |
LoseSNOA / S&P -12.38% / 2.41% |
WinSNOA / S&P 13.51% / 5.25% |
LoseSNOA / S&P -69.03% / 6.15% |
| 2024-Q31/3 |
LoseSNOA / S&P -26.90% / 5.89% |
WinSNOA / S&P 11.81% / 5.89% |
LoseSNOA / S&P -50.86% / 6.11% |
| 2024-Q22/3 |
WinSNOA / S&P 23.53% / 4.28% |
LoseSNOA / S&P -0.13% / 5.38% |
WinSNOA / S&P 463.82% / 5.12% |
| 2024-Q11/3 |
LoseSNOA / S&P -5.56% / 10.56% |
LoseSNOA / S&P -4.05% / 5.71% |
WinSNOA / S&P 394.74% / 5.59% |
| 2023-Q41/3 |
LoseSNOA / S&P -76.62% / 11.69% |
LoseSNOA / S&P -1.96% / 6.81% |
WinSNOA / S&P 242.42% / 7.78% |
| 2023-Q31/3 |
LoseSNOA / S&P -28.04% / -3.27% |
LoseSNOA / S&P -3.18% / 7.52% |
WinSNOA / S&P 247.00% / -5.03% |
| 2023-Q21/3 |
WinSNOA / S&P 9.18% / 8.74% |
LoseSNOA / S&P -1.63% / 9.50% |
LoseSNOA / S&P -11.11% / -8.57% |
| 2023-Q10/3 |
LoseSNOA / S&P -12.50% / 7.50% |
LoseSNOA / S&P 5.10% / 10.77% |
LoseSNOA / S&P -21.65% / -15.69% |
| 2022-Q40/3 |
LoseSNOA / S&P -47.42% / 7.56% |
LoseSNOA / S&P 0.55% / 11.88% |
LoseSNOA / S&P SNOA unavailable / -17.99% |
| 2022-Q30/3 |
LoseSNOA / S&P -27.05% / -4.88% |
LoseSNOA / S&P -13.82% / 13.47% |
LoseSNOA / S&P SNOA unavailable / -1.41% |
| 2022-Q20/3 |
LoseSNOA / S&P -27.18% / -16.10% |
LoseSNOA / S&P -21.87% / 13.71% |
LoseSNOA / S&P SNOA unavailable / 11.04% |
| 2022-Q10/3 |
LoseSNOA / S&P -12.06% / -4.60% |
LoseSNOA / S&P -32.21% / 15.97% |
LoseSNOA / S&P SNOA unavailable / 42.23% |
| 2021-Q40/3 |
LoseSNOA / S&P -18.28% / 11.03% |
LoseSNOA / S&P -39.92% / 15.00% |
LoseSNOA / S&P SNOA unavailable / 96.40% |
| 2021-Q30/3 |
LoseSNOA / S&P -23.98% / 0.58% |
LoseSNOA / S&P -28.27% / 10.77% |
LoseSNOA / S&P SNOA unavailable / 69.42% |
| 2021-Q20/3 |
LoseSNOA / S&P -1.21% / 8.55% |
LoseSNOA / S&P -13.83% / 6.58% |
LoseSNOA / S&P SNOA unavailable / 51.81% |
| 2021-Q11/3 |
LoseSNOA / S&P 2.34% / 6.17% |
WinSNOA / S&P 4.55% / -1.06% |
LoseSNOA / S&P SNOA unavailable / 7.39% |
| 2020-Q41/3 |
LoseSNOA / S&P -13.26% / 12.15% |
WinSNOA / S&P 16.18% / -3.72% |
LoseSNOA / S&P SNOA unavailable / -33.42% |
| 2020-Q32/3 |
WinSNOA / S&P 17.56% / 8.93% |
WinSNOA / S&P 7.82% / -2.04% |
LoseSNOA / S&P SNOA unavailable / -27.10% |
| 2020-Q22/3 |
WinSNOA / S&P 45.31% / 20.54% |
WinSNOA / S&P 1.13% / -0.46% |
LoseSNOA / S&P SNOA unavailable / -27.11% |
| 2020-Q11/3 |
WinSNOA / S&P 12.39% / -19.60% |
LoseSNOA / S&P -6.07% / 3.47% |
LoseSNOA / S&P SNOA unavailable / -14.75% |
| 2019-Q40/3 |
LoseSNOA / S&P -24.31% / 9.07% |
LoseSNOA / S&P -1.94% / 5.36% |
LoseSNOA / S&P SNOA unavailable / 2.99% |
| 2019-Q31/3 |
LoseSNOA / S&P -27.27% / 1.70% |
WinSNOA / S&P 5.44% / 5.02% |
LoseSNOA / S&P SNOA unavailable / 0.21% |
| 2019-Q21/3 |
LoseSNOA / S&P -6.38% / 4.30% |
WinSNOA / S&P 10.44% / 6.64% |
LoseSNOA / S&P SNOA unavailable / 8.65% |
| 2019-Q12/3 |
WinSNOA / S&P 32.39% / 13.65% |
WinSNOA / S&P 13.88% / 8.12% |
LoseSNOA / S&P SNOA unavailable / 14.29% |
| 2018-Q40/3 |
LoseSNOA / S&P -51.37% / -13.52% |
LoseSNOA / S&P 7.11% / 9.05% |
LoseSNOA / S&P SNOA unavailable / 18.23% |
| 2018-Q31/3 |
LoseSNOA / S&P -41.13% / 7.71% |
WinSNOA / S&P 14.51% / 10.21% |
LoseSNOA / S&P SNOA unavailable / 19.06% |
| 2018-Q21/3 |
LoseSNOA / S&P -32.61% / 3.43% |
WinSNOA / S&P 22.60% / 9.03% |
LoseSNOA / S&P SNOA unavailable / 14.46% |
| 2018-Q11/3 |
LoseSNOA / S&P -32.48% / -0.76% |
WinSNOA / S&P 29.88% / 7.68% |
LoseSNOA / S&P SNOA unavailable / 12.46% |
| 2017-Q41/3 |
LoseSNOA / S&P 4.41% / 6.64% |
WinSNOA / S&P 49.77% / 7.03% |
LoseSNOA / S&P SNOA unavailable / 13.82% |
| 2017-Q31/3 |
LoseSNOA / S&P -21.15% / 4.48% |
WinSNOA / S&P 48.18% / 5.68% |
LoseSNOA / S&P SNOA unavailable / 17.57% |
| 2017-Q21/3 |
LoseSNOA / S&P -7.67% / 3.09% |
WinSNOA / S&P 19.34% / 4.83% |
LoseSNOA / S&P SNOA unavailable / 17.74% |
| 2017-Q11/3 |
WinSNOA / S&P 42.26% / 6.07% |
LoseSNOA / S&P 0.27% / 3.67% |
LoseSNOA / S&P SNOA unavailable / 13.32% |
| 2016-Q41/3 |
WinSNOA / S&P 16.13% / 3.82% |
LoseSNOA / S&P -19.90% / 2.09% |
LoseSNOA / S&P SNOA unavailable / 7.05% |
| 2016-Q31/3 |
WinSNOA / S&P 8.23% / 3.85% |
LoseSNOA / S&P -29.72% / 0.20% |
LoseSNOA / S&P SNOA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SNOA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -70.11% | 20.78% |
| Annualized return | -70.11% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SNOA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.94% | 83.14% |
| Annualized return | -59.69% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | SNOA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.82% | 319.30% |
| Annualized return | -46.88% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |